Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pavia
Clinical trial register · Italy

Clinical Trials in Pavia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia117 Istituti Clinici Scientifici Maugeri SpA34 University of Pavia24 AstraZeneca23 Hoffmann-La Roche14
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Pavia

562 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Bari, Catania, Padova, Pavia, Pisa, Torino
2026-11-09
Not yet open
Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
NCT07418164Pancreatic Cancer, Biliopancreatic Diseases, Periampullary Neoplasms
IRCCS San Raffaele
Observational
2,500
Bergamo, Brescia, Cremona, Legnano, Mantua, Milan, Monza, Pavia
2026-10-31
Not yet open
Bayer
Observational
60
Pavia
2026-10-15
Not yet open
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 3
180
Pavia
2026-10-01
Not yet open
Effects of a 50+ Toothpaste on Halitosis and Oral Comfort in Healthy Adults
NCT07780474Oral Malodor (Halitosis), Oral Dryness
University of Pavia
Not applicable
30
Pavia
2026-10-01
Not yet open
Digital Patient Engagement in Technology-Supported Neurorehabilitation
NCT07794072Stroke, Parkinson Disease (PD), Motor Neuron Disease, Spinal Cord Injury
Catholic University, Italy
Observational
129
Milan, Montescano, Pavia
2026-10-01
Not yet open
Colchicine Effect on Amyotrophic Lateral Sclerosis Patients
NCT07813858Amyotrophic Lateral Sclerosis
DrugColchicine
Azienda Ospedaliero-Universitaria di Modena
Phase 2
87
Milan, Modena, Naples, Novara, Pavia
2026-10
Not yet open
Fondazione EMN Italy Onlus
Observational
92
Bari, Bologna, Brescia, Castelfranco Veneto, Como, Milan, Novara, Pavia
2026-10
Not yet open
Bristol-Myers Squibb
Phase 3
850
Meldola, Candiolo, Bergamo, Brescia, Milan, Pavia, Verona
2026-09-30
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
30
Pavia
2026-09-01
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Not applicable
60
Pavia, Telese Terme, Veruno
2026-09-01
Not yet open
University of Pavia
Observational
38
Milan, Pavia
2026-09-01
Not yet open
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
300
Pavia
2026-09
Not yet open
Epigenetic Changes in Long COVID Patients
NCT07757620Long COVID-19 Syndrome, Long COVID Symptoms
Istituti Clinici Scientifici Maugeri SpA
Observational
1,000
Cusano Milanino, Milan, Pavia
2026-09
Not yet open
Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach
NCT07147751Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL)
International Extranodal Lymphoma Study Group (IELSG)
Observational
100
Pavia
2026-09
Not yet open
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables
NCT07533084Active Aging Individuals Aged 65 and Over, Aging, Mild Cognitive Impairment (MCI), Dementia
Neuromed IRCCS
Observational
265
Brescia, Genova, Pozzilli, Milan, Pavia, Roma, Venezia
2026-09
Not yet open
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
10
Pavia
2026-09
Not yet open
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
2
Pavia
2026-09
Recruiting
Kardigan, Inc.
Phase 3
332
Bari, Florence, Milan, Padova, Pavia, Roma, Rozzano, Trieste
2026-08-26
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Ancona, Bergamo, Brescia, Milan, Pavia, Perugia, Riccione, Salerno
2026-08-24
Recruiting
University of Pavia
Not applicable
30
Pavia
2026-08-01
Recruiting
VectivBio AG
Phase 3
124
Pavia, Padova, Bologna, Florence, Milan, Torino
2026-08
Not yet open
VIPPSTAR-G1 Digital Early Intervention for Visual Impairment
NCT07717671Visual Impairment, Cerebral Visual Impairment, Neurodevelopmental Disorders, Prematurity
Università degli Studi di Brescia
Not applicable
150
Brescia, Pavia
2026-07-01
Recruiting
VirtualPark_Pediatric
NCT07580365Dystrophinopathy, Muscular Dystrophies, Congenital Myopathies
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato
Not applicable
22
Bosisio Parini, Pisa, Pavia, Salerno
2026-06-30
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Foggia, Forlì, Modena, Monza, Pavia, Rozzano, Siena, Torino
2026-06-11
Active, closed
AstraZeneca
Phase 2
326
Bologna, Florence, Milan, Padova, Pavia, Pisa, Torino, Torrette - Ancona
2026-06-11
Recruiting
Panuri Performance Study
NCT07587866Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A
Observational
1,100
Forlì, Milan, Pavia, Pisa, Roma, Rozzano
2026-06-10
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
150
Perugia, S. Andrea Delle Fratte, Florence, Milan, Pavia, Roma
2026-06-02
Recruiting
Comparison of Digital Analysis and Artificial Intelligence for Cephalometric Tracing
NCT07664488Cephalometric Analysis, Cephalometry, Artificial Intelligence (AI), Artificial Intelligence (AI) in Diagnosis
University of Pavia
Observational
100
Pavia
2026-06-01
Not yet open
Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients
NCT07616050Post-stroke, Parkinson Disease, Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment (MCI)
Marta Mondellini
Not applicable
70
Bari, Telese Terme, Costa Masnaga, Milan, Montescano, Pavia, Pisa
2026-06
Recruiting
Takeda
Phase 3
300
Florence, Rozzano, Pavia, Roma, Candiolo, Bologna, Milan, Naples
2026-05-21
Recruiting
Incyte Corporation
Phase 2
60
Bologna, Genova, Monza, Padua, Pavia, Rome
2026-05-20
Not yet open
Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging
NCT07474779Parkinson's Disease (PD), GBA1 Parkinson Disease, REM Sleep Behavior Disorder (iRBD)
University of Pavia
Not applicable
160
Pavia
2026-05-11
Recruiting
Hoffmann-La Roche
Phase 3
8
Rome, Pavia
2026-05-06
Not yet open
Stratification and Treatment in Early Psychosis Study - PROMOTE
NCT07434973Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, Clinical High Risk for Developing Psychosis
DrugCannabidiol
University of Oxford
Phase 3
586
Bari, Naples, Pavia, Roma
2026-05-01
Active, closed
Novo Nordisk A/S
Phase 3
606
Ferrara, Genoa, Pavia, Palermo, Padova, Verona, Bologna, Rozzano (MI)
2026-04-21
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Bari, Milan, Pavia
2026-04-16
Active, closed
University of Pavia
Observational
25
Pavia
2026-04-13
Recruiting
AirGo™ Respiratory Monitoring in Lung Resection
NCT07838025Respiratory Monitoring, Thoracic Surgery, Lung Resection Surgery, Respiratory Function
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
20
Pavia
2026-04-07
Recruiting
Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia
NCT07451977Chronic Respiratory Failure, Hypoxemia, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease
Istituti Clinici Scientifici Maugeri SpA
Not applicable
114
Lumezzane, Veruno, Montescano, Bari, Pavia, Taranto
2026-04-02
Active, closed
IRCCS National Neurological Institute "C. Mondino" Foundation
Observational
200
Pavia
2026-03-31
Recruiting
IRCCS National Neurological Institute "C. Mondino" Foundation
Observational
20
Pavia
2026-03-30
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
DrugZigakibart
Novartis Pharmaceuticals
Phase 2
32
Ranica, Brescia, Pavia
2026-03-26
Recruiting
Eisai Inc.
Phase 2
64
Bologna, Pavia, Verona
2026-03-26
Recruiting
Zanubritnib and Anti-MAG Neuropathy
NCT07392229Anti-MAG IgM-associated Demyelinating Polyneuropathy
DrugZanubrutinib
Azienda Ospedaliera di Padova
Phase 2
50
Milan, Padova, Pavia, Roma, Trieste
2026-03-24
Recruiting
Liaquat University of Medical & Health Sciences
Not applicable
132
Forlì, Ravenna, Rome, Brescia, Pavia, Turin, Catania, Florence
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 2
132
Ancona, Bari, Bologna, Messina, Milan, Pavia, San Giovanni Rotondo (FG), Verona
2026-03-23
Recruiting
SymBio Pharmaceuticals
Phase 3
180
Genova, Pavia, Perugia, Rome, San Raffaele
2026-03-17
Recruiting
Hoffmann-La Roche
Phase 2
360
Chieti, Naples, Salerno, Roma, Genoa, Milan, Pavia
2026-03-10
Recruiting
Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA
NCT07433946Ulcerative Colitis (Disorder), Crohn Disease, Malnutrition or Risk of Malnutrition, IBD
Lionhealth Srl Società Benefit
Not applicable
146
Rozzano, Naples, Pavia, Roma
2026-03-09
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Acquaviva delle Fonti, Bergamo, Messina, Milan, Pavia, Pisa, Roma, Rozzano
2026-03-03
Recruiting
Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis
NCT07491536Oral Mucositis, Chemotherapy-induced Oral Mucositis, Head and Neck Neoplasms
University of Pavia
Not applicable
50
Pavia
2026-03-01
Recruiting
Casa di Cura Dott. Pederzoli
Not applicable
185
Pavia, Peschiera del Garda
2026-02-26
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
150
Pavia
2026-02-24
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
425
Pavia
2026-02-20
Recruiting
Boehringer Ingelheim
Phase 3
286
Bari, Bologna, Milan, Palermo, Pavia, Varese
2026-02-16
Recruiting
Bayer
Phase 4
50
Bergamo, Bologna, Florence, Lecce, Milan, Naples, Padova, Pavia
2026-02-13
Recruiting
Kardigan, Inc.
Phase 2/3
332
Bari, Florence, Milan, Padova, Pavia, Roma, Rozzano, Trieste
2026-02-13
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Bergamo, Bologna, Cuneo, Florence, Palermo, Pavia, Pescara, Roma
2026-02-08
Recruiting
Alnylam Pharmaceuticals
Phase 3
125
Florence, Milan, Padova, Pavia, Roma
2026-02-03
Recruiting
Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11
NCT07356583Enterovirus, Clinical Syndrome, Respiratory Complications, Gastrointestinal
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,600
Pavia
2026-02-01
Not yet open
Associations Between Dental Anomalies and Ocular, Cutaneous and Skin Appendages Features
NCT06950619Congenital Cataract, Tooth Abnormalities, Ocular Pathologies
University of Pavia
Not applicable
5
Pavia
2026-02
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD)
European Institute of Oncology
Observational
150
Bologna, Forlì, Milan, Naples, Ortona, Pavia, Pisa, Roma
2026-01-28
By invitation
Thrombotic RIsk FActors in AL-goneurodystrophy
NCT07435207Algoneurodystrophy
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
120
Pavia
2026-01-26
Recruiting
Takeda
Phase 3
183
Catania, Pavia, Pescara, Roma, Torrette
2026-01-14
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
390
Meldola, Milan, Novara, Pavia, Perugia, Prato, Siena, Treviso
2026-01-12
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
419
Bari, Milan, Pavia, Torino, Veruno
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Bologna, Catania, Milan, Modena, Monza, Naples, Pavia, Roma
2026-01-07
Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
NCT07224581GRIN-related Neurodevelopmental Disorder
DrugRadiprodil
GRIN Therapeutics, Inc.
Phase 3
100
Florence, Pavia, Roma
2026-01-05
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
30
Pavia
2026-01-01
Not yet open
Extracorporeal Therapy and Therapeutic Drug Monitoring
NCT07287813ICU Patients With ECMO And-or RRT and With Gram Negative Infections Susceptible to BL-BLIs
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
40
Pavia
2025-12-12
Recruiting
Janssen Research & Development, LLC
Observational
200
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia
2025-12-04
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Milan, Naples, Palermo, Pavia, Roma, Rozzano
2025-12-03
Recruiting
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
NCT07203768Polycythemia Vera, Thrombocythemia
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
678
Pavia, Vicenza, Alessandria, Bergamo, Bologna, Brescia, Florence, Milan
2025-12-01
Recruiting
A Phase 2 Study of CRD-4730 in CPVT
NCT06658899Catecholaminergic Polymorphic Ventricular Tachycardia
DrugCRD-4730
Cardurion Pharmaceuticals, Inc.
Phase 2
12
Pavia
2025-12-01
Recruiting
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
NCT07448935AL Amyloidosis, POEMS Syndrome, Multiple Myeloma
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2025-11-28
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Brescia, Padova, Pavia, Pisa
2025-11-26
Recruiting
Optimal Time for Reperfusion in Acute Pulmonary Embolism
NCT07436702Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute
Azienda ULSS 8 Berica
Observational
500
Milan, Monselice, Pavia, Perugia, Pisa, Torino, Arzignano
2025-11-25
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Milan, Orbassano, Pavia, Roma
2025-11-24
Recruiting
Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device
NCT07092436Congenital and Acquired Neuromotor Disorders, Developmental Coordination Disorder (DCD)
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato
Not applicable
54
Bosisio Parini, Calambrone, Salerno, Genova, Milan, Pavia
2025-11-17
Recruiting
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
NCT07448779AL Amyloidosis, MGUS, Multiple Myeloma, Monoclonal Gammopathies
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2025-11-17
Recruiting
Therapeutic Music Listening in Post Stroke Patients.
NCT07432204Post Stroke, Anxiety, Depression
Istituti Clinici Scientifici Maugeri SpA
Not applicable
132
Pavia
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Ancona, Bergamo, Foggia, Pozzilli, Pavia, Roma, Gallarate, Naples
2025-11-11
Recruiting
AstraZeneca
Phase 2
435
Milan, Palermo, Pavia, Perugia, Roma, Rozzano, Torrette
2025-11-06
Recruiting
Takeda
Observational
10
Naples, Pavia
2025-11-03
By invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
NCT07287163Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Praxis Precision Medicines
Phase 3
700
Pozzilli, Bosisio Parini, Milan, Naples, Pavia, Pisa, Ponderano, Roma
2025-10-27
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
192
Pavia
2025-10-13
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
100
Pavia
2025-10-13
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
104
Pavia
2025-10-06
Recruiting
Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults
NCT07434154Type 1 Diabetes Mellitus, Latent Autoimmune Diabetes in Adult (LADA)
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
75
Pavia
2025-10-01
Recruiting
Needs of ALS Patients With C9orf72 Mutation and Their Caregivers
NCT07302321Amyotrophic Lateral Sclerosis
Istituto Auxologico Italiano
Observational
208
Milan, Pavia
2025-10-01
Not yet open
Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)
NCT07125664Acute Exacerbation Chronic Obstructive Pulmonary Disease
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 2
36
Pavia
2025-10-01
Recruiting
Early Prediction of Lung Injury in Preterm Infants Score
NCT07265583Respiratory Distress Syndrome RDS, Preterm Birth
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
104
Pavia
2025-10-01
Recruiting
AllRock Bio, Inc.
Phase 2
40
Foggia, Pavia, Rome
2025-10-01
Not yet open
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
10
Pavia
2025-10
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
40
Pavia
2025-09-30
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Bari, Genova, Naples, Pavia
2025-09-30
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
240
Pavia
2025-09-23
Recruiting
IM Bands in Inactive Hepatic CE
NCT07333612Cystic Echinococcosis
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2025-09-23
Recruiting
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis
NCT07251725Familial Pulmonary Fibrosis
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
126
Pavia
2025-09-17
Recruiting
Sanofi
Phase 3
942
Milan, Rozzano, Padova, Pavia, Reggio Emilia, Tradate (Va)
2025-09-16
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Gussago, Trieste, Bologna, Genova, Milan, Pavia
2025-09-16
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
413
Brescia, Florence, Milan, Padova, Pavia, Roma
2025-09-13
By invitation
University of Pavia
Observational
200
Pavia
2025-09-01
Recruiting
Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised and Healthy Cohorts
NCT07295535Immuno-modulation, Immuno-suppression, Immunocompromised Patients, Healthy Subjects
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
40
Pavia
2025-09-01
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
200
Pavia
2025-09-01
Recruiting
University of Pavia
Not applicable
40
Pavia
2025-08-30
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Bergamo, Bologna, Pavia
2025-08-28
Recruiting
Basilea Pharmaceutica
Phase 3
234
Genova, Milan, Modena, Pavia, Pisa, Trieste
2025-08-26
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
Bologna, Pavia, Roma, Rozzano
2025-08-22
Recruiting
Merz Therapeutics GmbH
Phase 3
990
Florence, Milan, Pavia, Roma
2025-08-21
Recruiting
Merz Therapeutics GmbH
Phase 3
780
Florence, Milan, Pavia, Roma
2025-08-21
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
NCT06927739Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease
Abcentra
Phase 2
240
Caserta, Ferrara, Brescia, Milan, Pavia
2025-08-11
Active, closed
GlaxoSmithKline
Phase 2
168
Milan, Palermo, Pavia, Siena
2025-08-06
Recruiting
Natural Bioactive Gel for Peri-Implantitis
NCT07088679Peri-implantitis, Dental Implants, Non-surgical Periodontal Therapy
University of Pavia
Not applicable
20
Pavia
2025-07-30
Recruiting
Lactoferrin-Based Oral Care for Periodontal Health in Pregnancy
NCT07069140Pregnancy, Periodontal Disease, Gingivitis, Oral Microbiota
University of Pavia
Not applicable
40
Pavia
2025-07-30
Recruiting
Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients
NCT07069127Celiac Disease, Dentin Hypersensitivity, Tooth Demineralization
University of Pavia
Not applicable
40
Pavia
2025-07-30
Recruiting
Hydroxyapatite Toothpastes and Enamel Remineralization:
NCT07069218Enamel Hypomineralization, Tooth Erosion
DrugToothpaste
University of Pavia
Not applicable
40
Pavia
2025-07-25
Recruiting
Celcuity Inc
Phase 3
1,180
Fano, Genova, Meldola, Milan, Modena, Naples, Parma, Pavia
2025-07-24
Recruiting
Takeda
Phase 3
347
Bologna, Brescia, Genoa, Messina, Milan, Pavia, Piacenza, Torino
2025-07-15
Active, closed
University of Pavia
Not applicable
60
Pavia
2025-07-10
Active, closed
European Myeloma Network B.V.
Phase 2
30
Pavia
2025-07-02
Recruiting
NORCE Norwegian Research Centre AS
Not applicable
600
Pavia
2025-07-01
Recruiting
Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy
NCT07029360Pregnancy, Periodontal Disease, Gingivitis, Dental Plaque
University of Pavia
Not applicable
40
Pavia
2025-07-01
By invitation
University of Pavia
Not applicable
20
Pavia
2025-07-01
Recruiting
Ipsen
Phase 2
132
Bologna, Milan, Pavia, Reggio Emilia
2025-06-30
Recruiting
AstraZeneca
Phase 2
987
Busto Arsizio, Cuneo, Ferrara, Milan, Monza, Naples, Pavia, Roma
2025-06-27
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Bergamo, Foggia, Genova, Milan, Pavia, Roma
2025-06-23
Recruiting
Multitarget Strategy for Primary Podocytopathies
NCT06718894Nephrotic Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
150
Milan, Pavia
2025-06-19
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Rozzano, Acquaviva delle Fonti, Bergamo, Cuneo, Livorno, Milan, Naples, Pavia
2025-06-19
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2025-06-09
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bergamo, Bologna, Brescia, Meldola, Milan, Pavia, Perugia, Pesaro
2025-06-04
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
60
Pavia
2025-06-01
Recruiting
High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project
NCT06822231Critical Illness Myopathy, Guillain Barré Syndrome, Critical Illness Polyneuromyopathy (CIPNM)
Istituti Clinici Scientifici Maugeri SpA
Not applicable
124
Bari, Genova, Milan, Modena, Montescano, Pavia, Roma, Telese Terme
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Castellana Grotte, Pavia, Legnano, Rozzano, San Donato Milanese, Segrate, Turin, Bologna
2025-05-27
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bergamo, Naples, Pavia, Pisa, Roma, Rozzano
2025-05-20
Recruiting
Fondazione Don Carlo Gnocchi ETS
Not applicable
160
Acerenza, Bari, Genova, Messina, Milan, Montescano, Pavia, Rome
2025-05-20
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
500
Pavia
2025-05-17
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Pavia, Roma
2025-05-15
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
587
Bologna, Florence, Pavia, Pisa, Roma, Rome
2025-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Milan, Verona, Bologna, Genova, Pavia, Roma, Sassari
2025-05-12
Recruiting
Takeda
Phase 3
225
Ancona, Turin, Florence, Milan, Pavia, Reggio Calabria, Rome, Rozzano
2025-05-06
Recruiting
Takeda
Phase 3
59
Milan, Rozzano, Orbassano, Brescia, Genova, Messina, Pavia, Pisa
2025-05-06
Recruiting
Unmet Needs Among Patients With Isolated REM Sleep Behavior Disorder (iRBD) and Their Significant Others
NCT07498452REM Sleep Behavior Disorder, Isolated REM Sleep Behavior Disorder
Universita di Verona
Observational
150
Bologna, Genoa, Milan, Pavia, Cagliari, Troina, Pisa, Verona
2025-05-06
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2025-05-01
Recruiting
Enea Parimbelli
Not applicable
20
Pavia
2025-05
Recruiting
High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project
NCT06881979Amyotrophic Lateral Sclerosis, Chronic Inflammatory Demyelinating Neuropathy, Charcot-Marie-Tooth Disease
Istituti Clinici Scientifici Maugeri SpA
Not applicable
60
Genova, Milan, Modena, Montescano, Pavia, Roma, Telese Terme
2025-04-28
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT06951217Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.
Phase 2
340
Pavia, Milan
2025-04-17
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Bergamo, Pavia, Roma
2025-04-16
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
NCT06906341Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms, Endometrial Cancer
DrugsNab-paclitaxel /m^2·Relacorilant·Bevacizumab
Corcept Therapeutics
Phase 2
270
Catania, Milan, Pavia, Rome, Torino, Treviso
2025-04-11
Recruiting
BeOne Medicines
Phase 3
250
Bari, Florence, Milan, Naples, Novara, Pavia, Perugia, Roma
2025-04-10
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
30
Pavia
2025-04-10
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
108
Pavia
2025-04-08
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
144
Milan, Palermo, Pavia
2025-04-03
Active, closed
Racial Disparities in Acute Stroke
NCT06955442Ischemic Stroke
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
4,500
Bologna, Crema, Frosinone, Genova, Lecce, Naples, Pavia, Pozzilli
2025-04-03
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Genoa, Milan, Rozzano, Rome, Pavia, Pisa
2025-04-01
Recruiting
A Story for Pepper & Nao
NCT06797050Children and Adolescents With Neuromotor Impairment
IRCCS Fondazione Stella Maris
Not applicable
80
Bosisio Parini, Pavia, Calambrone
2025-04-01
Recruiting
Centro Cardiologico Monzino
Phase 2
102
Pavia, Ancona, Milan, Naples
2025-03-31
Recruiting
Wissenschaftliches Institut Bethanien e.V
Observational
1,800
Milan, Pavia
2025-03-24
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2025-03-21
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2025-03-18
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Bergamo, Bologna, Brescia, Milan, Pavia, Pisa, Roma, Siena
2025-03-18
Recruiting
AstraZeneca
Phase 3
990
Cona, Florence, Milan, Montebelluna, Naples, Pavia, Roma, Sassari
2025-03-18
Recruiting
Hoffmann-La Roche
Phase 3
600
Bari, Catanzaro, Naples, Rome, Milan, Monza MI, Pavia, Rho
2025-03-17
By invitation
University of Pavia
Not applicable
30
Pavia
2025-03-15
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
20
Pavia
2025-03-15
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
400
Pavia
2025-03-14
Recruiting
AstraZeneca
Phase 2
80
Bologna, Castelfranco Veneto, Florence, Milan, Naples, Pavia, Pisa, Roma
2025-03-12
Recruiting
Pfizer
Phase 3
723
Avezzano, Rome, Bologna, Florence, Milan, Pavia, Roma
2025-03-11
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
15
Pavia
2025-03-07
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
150
Pavia, Brescia, Milan, Monza
2025-03-06
Recruiting
AI System for Detection and Characterization of Chronic Enteropathies
NCT07387185Celiac Disease, Small Bowel Mucosal Atrophy or Lesions, Non-celiac Enteropathies
Istituti Clinici Scientifici Maugeri SpA
Observational
380
Pavia
2025-02-20
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
30
Pavia
2025-02-17
Active, closed
Meditation and Psychophysical Well-Being in Elderly
NCT06872502Loneliness, Psychophysical Well-being
University of Pavia
Not applicable
60
Pavia
2025-02-15
By invitation
Longboard Pharmaceuticals
Phase 3
324
Florence, Genoa, Milan, Pavia, Rome, Verona
2025-02-12
Active, closed
AbbVie
Phase 3
468
Florence, Milan, Naples, Rome, Latina, Pavia, Perugia, Udine
2025-02-10
Recruiting
Dianthus Therapeutics
Phase 3
256
Bergamo, Bologna, Genova, Gussago, Milan, Modena, Monza, Pavia
2025-02-10
Recruiting
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
NCT06651970Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
DrugAcalabrutinib
AstraZeneca
Phase 4
60
Cagliari, Florence, Milan, Pavia, Perugia
2025-02-04
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Bologna, Cagliari, Florence, Milan, Naples, Padova, Palermo, Pavia
2025-01-28
Recruiting
Fondazione del Piemonte per l'Oncologia
Not applicable
300
Candiolo, Pavia
2025-01-23
Recruiting
IRCCS Policlinico S. Donato
Not applicable
30,000
Milan, Ancona, Genova, Naples, Palermo, Pavia, Pozzilli, Rome
2025-01-22
Active, closed
A Pilot Study to Assess Optimal Prevention and Outcome Improvement in Young Ischemic Stroke
NCT06820411Ischemic Stroke at a Young Age, Secondary Prevention
IRCCS National Neurological Institute "C. Mondino" Foundation
Not applicable
36
Pavia
2025-01-20
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
300
Pavia
2025-01-17
Recruiting
I.R.C.C.S. Fondazione Santa Lucia
Not applicable
60
Pavia, Roma
2025-01-15
By invitation
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
3
Pavia
2025-01-15
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
400
Bergamo, Bologna, Genova, Milan, Padova, Palermo, Pavia, Roma
2025-01-10
Recruiting
Novo Nordisk A/S
Phase 3
480
Orbassano, Padova, Pavia
2025-01-10
Recruiting
Janssen Research & Development, LLC
Phase 3
750
Ancona, Brescia, Catania, Milan, Naples, Pavia, Roma, Rozzano
2025-01-09
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Observational
50
Pavia
2025-01-01
Not yet open
Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
NCT06186336Chronic Coronary Syndrome, Coronary Artery Disease, Stable Angina, Acute Coronary Syndrome
GE Healthcare
Observational
200
Pavia
2025-01
Active, closed
mAbxience Research S.L.
Phase 3
726
Brescia, Cremona, Genova, Lecce, Meldola, Pavia, Roma, Siena
2024-12-30
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Phase 2
28
Pavia
2024-12-24
Recruiting
Pembrolizumab in High-risk Thyroid Cancer
NCT05852223Differentiated Thyroid Cancer
DrugPembrolizumab
Istituti Clinici Scientifici Maugeri SpA
Phase 2
25
Pavia
2024-12-20
Recruiting
GlaxoSmithKline
Phase 3
520
Ancona, Catania, Meldola FC, Palermo, Pavia, Pisa, Roma
2024-12-16
Recruiting
Basilea Pharmaceutica
Phase 3
450
Cuneo, Genoa, Milan, Modena, Pavia, Pisa, Siena, Trieste
2024-12-11
Active, closed
PPM Services S.A.
Phase 3
400
Ancona, Florence, Genova, Parma, Pavia, Roma, Bologna, Catania
2024-12-05
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Bologna, Florence, Pavia
2024-12-03
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Ancona, Bologna, Florence, Milan, Pavia, Roma, Torino
2024-12-03
Recruiting
Anna Estraneo
Not applicable
118
Sant'Angelo dei Lombardi, Bari, Telese Terme, Genova, Milan, Pavia
2024-12-02
Recruiting
IRCCS National Neurological Institute "C. Mondino" Foundation
Observational
30
Pavia
2024-12-01
Recruiting
Cognitive Evaluation of Patients With Eating Disorders
NCT07478510ARFID, Anorexia Nervosa, Bulimia Nervosa, Cognitive Flexibility
Istituti Clinici Scientifici Maugeri SpA
Observational
84
Pavia, Milan
2024-11-26
Active, closed
AbbVie
Observational
1,314
Milan, Naples, Turin, Rome, Ancona, Bari, Catanzaro, Pavia
2024-11-26
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
20
Pavia
2024-11-26
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
200
Pavia
2024-11-22
Active, closed
Pfizer
Phase 3
200
L’Aquila, Bari, Milan, Rome, Brescia, Latina, Pavia, Roma
2024-11-15
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Florence, Genoa, Milan, Pavia, Rome, Verona
2024-11-11
Recruiting
Prismatic Adaptation in Cognitive Rehabilitation
NCT06920784Traumatic Brain Injury
Istituti Clinici Scientifici Maugeri SpA
Not applicable
50
Bari, Pavia, Sciacca, Telese Terme
2024-11-07
Recruiting
IRCCS Fondazione Stella Maris
Not applicable
194
Genova, Bosisio Parini, Milan, Pavia, Calambrone, Salerno
2024-11-04
Recruiting
University College Cork
Observational
300
Feltre, Bari, Milan, Naples, Pavia
2024-11-04
Recruiting
Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities
NCT06380530Musculoskeletal Deformity, Musculoskeletal Abnormalities, Musculoskeletal Disorder
Istituto Ortopedico Rizzoli
Not applicable
100
Bologna, Rozzano, Genova, Milan, Pavia, Roma
2024-10-31
Recruiting
Istituto Ortopedico Rizzoli
Observational
1,000
Bologna, Genova, Milan, Pavia, Roma, Rozzano
2024-10-31
Recruiting
Abivax S.A.
Phase 2
212
Bologna, Catanzaro, Milan, Negrar, Pavia, Roma, Rozzano, San Giovanni Rotondo
2024-10-30
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Genova, Pavia, Naples, Palermo, Roma
2024-10-29
Recruiting
IRCCS Eugenio Medea
Not applicable
40
Bosisio Parini, Calambrone, Milan, Pavia, Roma, Salerno
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Foggia, Monza, Palermo, Pavia, Roma, Sassari, Ivrea, Trieste
2024-10-24
Recruiting
TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial
NCT06685744Parkinson Disease, Multiple Sclerosis, Neurologic Diseases, General
Fondazione Don Carlo Gnocchi ETS
Not applicable
300
Bari, Genova, Lecco, Milan, Modena, Pavia
2024-10-23
Recruiting
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NCT06681012Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl
Not applicable
330
Bologna, Milan, Naples, Padova, Pavia, Pisa, Roma
2024-10-22
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
14
Pavia
2024-10-21
Recruiting
Novartis Pharmaceuticals
Phase 2
200
Ancona, Milan, Rozzano, Modena, Palermo, Pavia, Roma, Verona
2024-10-09
Recruiting
AbbVie
Phase 2
488
Milan, Pavia, Roma
2024-10-07
Recruiting
Effect of Cognitive Behavioral Play Intervention and Epilepsy
NCT06813612Epilepsy, Epilepsy in Children
IRCCS National Neurological Institute "C. Mondino" Foundation
Not applicable
52
Pavia
2024-10-07
Active, closed
Longboard Pharmaceuticals
Phase 3
96
Florence, Genoa, Pavia, Rome, Verona
2024-09-25
Active, closed
Hoffmann-La Roche
Phase 3
400
Matera, Naples, Rome, Pavia, Rho
2024-09-17
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
60
Pavia
2024-09-17
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Meldola, Genoa, Milan, Alessandria, Ascoli Piceno, Pavia, Ravenna
2024-09-16
Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
NCT06559150Non-cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Phase 2
284
Bologna, Monza, Rozzano, Pavia, Catania
2024-09-11
Recruiting
GlaxoSmithKline
Phase 3
440
Ancona, Milan, Modena, Naples, Padova, Palermo, Pavia, Pisa
2024-09-11
Recruiting
Laura Deborah Locati
Not applicable
60
Naples, Pavia, Sassari
2024-09-09
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Alessandria, Ancona, Genova, Milan, Rozzano, Pescara, Pisa, Pavia
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Bologna, Naples, Pavia, Roma
2024-09-03
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Bari, Genova, Modena, Pavia, Rome
2024-08-30
Recruiting
Jazz Pharmaceuticals
Phase 3
550
Aviano, Bergamo, Bologna, Milan, Modena, Monza, Padova, Pavia
2024-08-13
Active, closed
Fidia Farmaceutici s.p.a.
Not applicable
156
Bologna, Florence, Padova, Pavia, Roma, Torino, Milan
2024-08-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Bologna, Genova, Milan, Mirano, Pavia, Reggio Emilia, Terni
2024-07-31
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-07-30
Recruiting
Vor Biopharma
Phase 3
180
San Giovanni Rotondo, Naples, Cefalù, Pavia, Rome
2024-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Florence, Alessandria, Bologna, Milan, Pavia, Roma, Varese
2024-07-16
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Milan, Rozzano, Rome, Messina, Palermo, Pavia, Pisa
2024-07-12
Recruiting
Case-Finding for Neurocognitive Disorders in Pavia
NCT06983119Dementia, Mild Cognitive Impairment
IRCCS National Neurological Institute "C. Mondino" Foundation
Not applicable
490
Pavia
2024-07-11
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
50
Pavia
2024-07-08
Recruiting
Lifestyle and Nutrition Evaluation in Physically Active People and Athletes
NCT06881745Dietary Habits, Nutritional Status, Body Composition, Athlete
University of Pavia
Observational
181
Pavia
2024-07-05
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
200
Pavia
2024-06-30
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
31
Arezzo, Bolzano, Catania, Pavia, Piacenza
2024-06-30
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
400
Pavia
2024-06-25
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Bergamo, Bologna, Genova, Milan, Pavia, Rome, Treviso
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Ancona, Bari, Catania, Milan, Padova, Palermo, Pavia, Pisa
2024-06-20
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
14
Pavia
2024-06-18
Active, closed
Unravelling the Role of Apoptosis in Platelets Biogenesis Through the Study of the Thrombocytopenia THC4
NCT07026578Thrombocytopenia, Isolated, Thrombocytopenia 4, CYCS MUTATION- ASSOCIATED THROMBOCYTOPENIA THC4
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
38
Pavia
2024-06-18
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bergamo, Foggia, Genova, Naples, Pavia, Roma, Rozzano
2024-06-17
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
150
Pavia
2024-05-24
Recruiting
University Hospital, Antwerp
Phase 3
174
Milan, Arezzo, Bergamo, Brescia, Florence, Lecco, Pavia, Pisa
2024-05-24
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
400
Pavia
2024-05-23
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Alessandria, Lecco, Milan, Monza, Naples, Pavia, Modena, Roma
2024-05-20
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Milan, Naples, Padova, Pavia, Roma
2024-05-15
By invitation
University of Pavia
Not applicable
20
Pavia
2024-05-15
Active, closed
European Myeloma Network B.V.
Phase 2
50
Bari, Bergamo, Florence, Genova, Meldola, Novara, Padova, Pavia
2024-05-14
Active, closed
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC)
DrugsKeytruda·Pembrolizumab
Inhibrx Biosciences, Inc
Phase 2/3
410
Naples, Milan, Pavia
2024-05-14
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-05-13
Recruiting
BNP in Pediatric Metabolic Syndrome
NCT07181733Metabolic Syndrome
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Pavia
2024-05-08
Recruiting
W.L.Gore & Associates
Observational
2,000
Ancona, Bari, Pavia, Torino, Verona
2024-05-07
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
56
Avellino, Alessandria, Biella, Milan, Novara, Pavia, Piacenza, Torino
2024-05-07
Active, closed
Hoffmann-La Roche
Phase 2
256
Tricase (LE), Rome, Milan, Pavia
2024-05-02
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
534
Pavia
2024-04-29
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Milan, Orbassano, Torino, Bologna, Genova, Meldola, Novara, Pavia
2024-04-22
Recruiting
AstraZeneca
Phase 3
675
Bergamo, Genoa, Milan, Monza, Padova, Pavia, Ravenna, Roma
2024-04-11
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
12
Pavia
2024-04-10
Recruiting
ACU_Knee: Role of Acupuncture in Knee Prosthetic Surgery
NCT07123805Acupuncture Analgesia, Acupuncture, Acupuncture Therapy, Total Knee Anthroplasty
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
80
Pavia
2024-04-10
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
150
Pavia
2024-04-04
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
375
Torrette, Naples, Bologna, Venezia, Pavia, Milan, Rozzano, Catania
2024-04-03
Recruiting
AbbVie
Phase 1/2
76
Bologna, Pavia
2024-04-01
Recruiting
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
NCT06409832Migraine, Migraine With Aura, Migraine Without Aura
DrugRimegepant
University of Florence
Observational
100
Florence, Pavia
2024-03-26
Active, closed
Gilead Sciences
Phase 3
577
Brescia, Foggia, Milan, Monza, Pavia, Roma
2024-03-25
Recruiting
GlaxoSmithKline
Phase 3
864
Bolzano, Bologna, Milan, Naples, Pavia, Prato, Roma, Rozzano MI
2024-03-21
By invitation
University of Pavia
Not applicable
40
Pavia
2024-03-20
Recruiting
Multiple Sclerosis and the Effects of Ketogenic Diet Therapy
NCT06715436Multiple Sclerosis, Relapsing-Remitting
IRCCS National Neurological Institute "C. Mondino" Foundation
Not applicable
111
Pavia
2024-03-15
By invitation
University of Pavia
Not applicable
40
Pavia
2024-03-10
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
2,500
Pavia
2024-03-01
Recruiting
Takeda
Phase 3
50
Pavia
2024-03-01
Recruiting
A Prospective Randomized Trial of ECP in Subclinical AMR
NCT06112951Antibody-mediated Rejection, Lung Transplant Rejection
Medical University of Vienna
Not applicable
80
Pavia
2024-03-01
Active, closed
Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Crowns Made by Different Materials
NCT06288919Dental Implant Failed, Peri-implant Mucositis, Peri-Implantitis
University of Pavia
Not applicable
120
Pavia
2024-03-01
Active, closed
AstraZeneca
Phase 2
142
Bari, Bologna, Milan, Naples, Palermo, Pavia, Peschiera del Garda
2024-02-22
Recruiting
AstraZeneca
Phase 3
5,250
Ancona, Florence, Genoa, Mestre, Milan, Naples, Pavia, Perugia
2024-02-21
Active, closed
ViiV Healthcare
Phase 3
307
Bari, Bergamo, Padova, Pavia, Sassari
2024-02-21
Active, closed
Novo Nordisk A/S
Phase 2
80
Pisa, Pavia
2024-02-20
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
62
Pavia
2024-02-18
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
193
Pavia
2024-02-14
Active, closed
Astellas Gene Therapies
Not applicable
119
Florence, Gussago, Messina, Milan, Pavia, Pisa, Roma, Udine
2024-02-01
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
600
Pavia
2024-01-26
Active, closed
Shock Wave Therapy Plus Exercise in GTPS
NCT06248905Greater Trochanteric Pain Syndrome of Both Lower Limbs
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
80
Pavia
2024-01-26
Recruiting
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
NCT06251778Amyloidosis, Amyloidosis Cardiac, ATTR Amyloidosis Wild Type
Paolo Milani
Observational
200
Pavia
2024-01-26
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
825
Pavia
2024-01-26
Recruiting
Genexine, Inc.
Phase 3
429
Brescia, Florence, Foggia, Genova, Pavia, Pisa, Verona
2024-01-25
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Alessandria, Bologna, Brindisi, Catania, Genova, Legnano, Milan, Pavia
2024-01-22
Active, closed
DualityBio Inc.
Phase 3
541
Bergamo, Brescia, Catania, Catanzaro, Milan, Pavia, Verona, Naples
2024-01-18
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Bologna, Florence, Milan, Novara, Padua, Pavia, Roma
2024-01-11
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
10
Pavia
2024-01-11
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Not applicable
54
Pavia
2024-01-08
By invitation
Sanofi
Phase 3
90
Milan, Padua, Rome, Naples, Pavia
2024-01-03
Recruiting
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
NCT07159750Migraine, Episodic Migraine, Chronic Migraine, Headache
Hospital Universitari Vall d'Hebron Research Institute
Observational
700
L’Aquila, Modena, Pavia, Roma
2024-01-02
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
400
Pavia
2024-01-01
Active, closed
Bioprojet
Phase 2
62
Bologna, Bosisio Parini, Cagliari, Calambrone, Foggia, Messina, Naples, Pavia
2023-12-20
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
DrugZipalertinib
Taiho Oncology, Inc.
Phase 3
285
Meldola, Genova, Milan, Modena, Pavia, Ravenna, Roma, Verona
2023-12-18
Recruiting
AstraZeneca
Phase 3
1,145
Aviano, Florence, Milan, Modena, Naples, Padova, Pavia, Rozzano
2023-12-14
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Meldola, Monza, Turin, Milan, Modena, Naples, Novara, Pavia
2023-12-13
Recruiting
Intellia Therapeutics
Phase 3
1,200
Bologna, Cona, Florence, Genova, Pavia, Pisa, Trieste
2023-12-13
Active, closed
AnaptysBio, Inc.
Phase 2
132
Bologna, Cagliari, Catania, Legnano, Milan, Pavia, Rozzano, San Donato
2023-12-04
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
16
Pavia
2023-12-04
Active, closed
argenx
Observational
413
Florence, Gussago, Messina, Novara, Orbassano, Palermo, Pavia, Pisa
2023-11-29
Recruiting
CNAO National Center of Oncological Hadrontherapy
Not applicable
42
Pavia
2023-11-28
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
600
Pavia
2023-11-17
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
120
Pavia
2023-11-17
Active, closed
medac GmbH
Phase 2
49
Bologna, Monza, Pavia, Rome, Turin
2023-11-13
Active, closed
AstraZeneca
Phase 3
895
Bari, Bergamo, Milan, Padova, Parma, Pavia, Ravenna, Roma
2023-10-24
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 2
114
Bologna, Brescia, Milan, Pavia, Roma, Udine
2023-10-23
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
80
Pavia
2023-10-20
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
80
Pavia
2023-10-16
Recruiting
Local Registry of Primary Cutaneous T-cell Lymphomas
NCT07160023Primary Cutaneous T-cell Lymphomas NCT Number
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
600
Pavia
2023-10-12
Active, closed
Ipsen
Phase 3
759
Bologna, Naples, Pavia, Pozzilli, Roma
2023-10-12
Recruiting
Sanofi
Phase 3
180
Milan, Padua, Palermo, Pavia, Siena
2023-10-10
Active, closed
Bristol-Myers Squibb
Phase 3
106
Reggio Calabria, Naples, Rome, Pavia, Rozzano (MI), Novara, Turin, Florence
2023-10-05
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Tricase, Milan, Meldola, Borgo Roma, Alessandria, Genova, Parma, Pavia
2023-10-04
Active, closed
Tensive SRL
Not applicable
92
Rozzano, Catania, Milan, Pavia, Pisa, Roma, Torino
2023-09-29
Active, closed
Boehringer Ingelheim
Phase 2
268
Florence, Palermo, Pavia, Rozzano (MI), Verona
2023-09-08
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Bologna, Castelfranco Veneto, Cuneo, Latina, Lecce, Milan, Modena, Pavia
2023-09-05
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
200
Pavia
2023-09-01
Recruiting
Ipsen
Phase 3
276
Modena, Monza, Naples, Padova, Palermo, Pavia, Pisa, San Giovanni Rotondo
2023-08-31
Active, closed
AnaptysBio, Inc.
Phase 2
420
Milan, Pavia, Bari, Novara, Roma
2023-08-31
Recruiting
AstraZeneca
Phase 3
231
Genova, Pavia, Roma
2023-08-24
Recruiting
DAratumumab and REvlimid REfractory MM
NCT06541860Multiple Myeloma
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2023-08-21
Active, closed
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)
NCT05792332Atypical Parkinsonism, MSA - Multiple System Atrophy, PSP, Nurse-Patient Relations
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Not applicable
164
Messina, Milan, Pavia, Pozzilli
2023-08-17
Active, closed
Hoffmann-La Roche
Phase 3
459
Bari, Naples, Bologna, Rome, Genoa, Pavia, Turin
2023-08-08
Recruiting
Flavolife Srl
Not applicable
60
Pavia
2023-08-04
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Pavia
2023-07-27
Recruiting
Coping and Attachment in Pediatric Oncohematology
NCT06858163Pediatric Cancer, Coping Behavior, Relationship, Parent Child
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
60
Monza, Pavia, Taranto
2023-07-12
Active, closed
Novartis Pharmaceuticals
Phase 3
100
Florence, Pavia, Siena
2023-07-11
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bari, Foggia, Naples, Modena, Trieste, Pavia, Ranica
2023-07-06
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Naples, Cona, Ferrara, Pavia, Catania, Palermo
2023-06-28
Recruiting
Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
NCT06899854Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
53
Pavia
2023-06-19
Recruiting
Gepant treAtments: EffectIveNess and tolERability (GAINER)
NCT05903027Migraine, Migraine With Aura, Migraine Without Aura, Chronic Migraine
University of Florence
Observational
100
Florence, Pavia
2023-06-15
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
60
Pavia
2023-06-15
Recruiting
H. Lundbeck A/S
Phase 3
315
Cagliari, Genoa, Milan, Pavia, Pisa, Rome
2023-06-08
Recruiting
Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
NCT06782074Epilepsy, Quality of Life, Neuropathology, Emotional Problem
IRCCS National Neurological Institute "C. Mondino" Foundation
Observational
96
Pavia
2023-06-01
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
180
Pavia
2023-06-01
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
70
Pavia
2023-06-01
Recruiting
IRCCS National Neurological Institute "C. Mondino" Foundation
Observational
90
Pavia
2023-06-01
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Observational
1,064
Pavia
2023-05-31
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Observational
262
Pavia
2023-05-31
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
40
Pavia
2023-05-30
Recruiting
Pfizer
Phase 2
100
Naples, Genoa, Monza, Rome, Catania, Padova, Pavia, Torino
2023-05-17
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
300
Pavia
2023-05-16
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Brescia, Catania, Florence, Pavia, Roma, Naples
2023-05-11
Recruiting
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
NCT06383143AL Amyloidosis, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
760
Bari, Catania, Pavia, Torino
2023-05-01
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Observational
1,400
Pavia
2023-04-26
Active, closed
BeOne Medicines
Phase 2/3
178
Pavia
2023-04-17
Recruiting
HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
NCT05947149Head and Neck Cancer, Skull Base--Cancer, Brain Cancer
CNAO National Center of Oncological Hadrontherapy
Observational
180
Pavia
2023-03-27
Active, closed
Insmed Incorporated
Phase 2/3
91
Pavia, Monza, Palermo, Roma
2023-03-07
Recruiting
Takeda
Phase 3
160
Milan, Palermo, Pavia, Rozzano
2023-03-06
Recruiting
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
NCT05327062Cardiac Resynchronization Therapy, Chronic Heart Failure, Left Bundle-Branch Block
XSpline S.p.A.
Not applicable
150
Pavia, Roma, Bolzano, Rovereto
2023-03-06
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Chieti, Bari, Modena, Parma, Rome, San Donato Milanese (MI), Latina, Pavia
2023-03-01
Recruiting
FDG-PET in the Diagnosis of Autoimmune Encephalitis
NCT06019975Autoimmune Encephalitis
University of Milano Bicocca
Observational
90
Udine, Genoa, Pavia, Milan, Monza
2023-03-01
Active, closed
AlgoTherapeutix
Phase 2
276
Campobasso, Meldola, Milan, Monza, Pavia, Roma
2023-02-28
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
400
Pavia
2023-02-03
Recruiting
Tenaya Therapeutics
Observational
200
Milan, Pavia
2023-01-31
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
156
Telese Terme, Lumezzane, Montescano, Tradate, Bari, Pavia
2023-01-26
Active, closed
Cenobamate in Adults With Focal-Onset Seizures
NCT05859854Epilepsy, Focal-Onset Seizure, Neurological Disorder
Aziende Chimiche Riunite Angelini Francesco S.p.A
Observational
936
Bari, Catanzaro, Pozzilli, Pavia, Roma, Torino, Conegliano, Udine
2023-01-24
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
44
Pavia
2023-01-19
Recruiting
Monocentric Prospectiv Observational Clinical Trial of Pelvic Floor Biometry During Pregnancy and Puerperium
NCT06867341Pelvic Floor Disorders, Pelvic Floor Distress and Impact Scores
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
350
Pavia
2023-01-17
Recruiting
GBG Forschungs GmbH
Phase 2
170
Alessandria, Ancona, Carpi, Lecco, Legnago, Milan, Pavia, Udine
2023-01-02
Recruiting
The Echodynamic Approach
NCT06859047Echocardiography, Transthoracic, Right-heart Hemodynamics
IRCCS Ospedale San Raffaele
Observational
200
Bari, Milan, Pavia
2023-01-01
Recruiting
Physical Activity on Neuroinflammation in Parkinson's Disease
NCT06977204Parkinson Disease, Physical Inactivity, Physical Disability
IRCCS National Neurological Institute "C. Mondino" Foundation
Observational
40
Pavia
2023-01-01
Active, closed
Harmonic Ratio in Patients With GLUT1 Deficiency Syndrome
NCT05887739GLUT1DS1, Dystonia, Gait Disorders, Neurologic, Gait Ataxia
IRCCS National Neurological Institute "C. Mondino" Foundation
Observational
32
Pavia
2023-01-01
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Battipaglia, Naples, Ferrara, Pavia, Catania, Palermo
2022-12-29
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Bologna, Genova, Milan, Modena, Naples, Novara, Padova, Pavia
2022-12-16
Recruiting
Neurosurgical Outcome Network
NCT06724029Aneurysms, Arteriovenous Malformations, Cavernomas, Skull Base Tumors
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
4,500
Bergamo, Brescia, Gravedona, Como, Cremona, Monza, Pavia, Sondrio
2022-12-05
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
80
Pavia
2022-12-01
By invitation
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Ancona, Florence, Padova, Pavia, Pisa, Roma
2022-11-30
Active, closed
Sanofi
Phase 2
187
Bolzano, Milan, Rozzano, Rome, Catanzaro, Palermo, Pavia
2022-11-25
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
101
Pavia
2022-11-22
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
100
Pavia
2022-11-14
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2
87
Milan, Pavia, Rozzano, Turin, Roma
2022-11-07
Recruiting
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
NCT07146503Depression and Quality of Life, Treatment Resistant Depression (TRD), Anhedonia, Apathy
DrugsIntranasal·Esketamine
Riccardo Guglielmo
Observational
100
Genova, Chieti, Milan, Pavia
2022-11-01
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Genova, Legnago, Pavia, Treviglio, Verona
2022-10-27
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Bergamo, Bologna, Florence, Milan, Naples, Pavia, Roma, Rozzano
2022-10-25
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Naples, Modena, Rome, Genoa, Milan, Pavia, Turin, Florence
2022-10-14
Active, closed
Gilead Sciences
Phase 3
1,021
Avellino, Cremona, Genova, Milan, Naples, Pavia, Pesaro, Piacenza
2022-10-12
Active, closed
Hoffmann-La Roche
Phase 3
122
Naples, Genoa, Milan, Pavia, Palermo
2022-09-27
Recruiting
Janssen Research & Development, LLC
Phase 2/3
201
Catania, Genova, Milan, Naples, Orbassano, Pavia, Roma, Rozzano
2022-09-23
Recruiting
Celgene
Phase 3
810
Meldola, Rome, Catania, Bologna, Pavia
2022-09-20
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Milan, Naples, Orbassano, Pavia, Verona
2022-09-19
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
429
Bergamo, Milan, Pavia, Varese, Padova, Verona, Vicenza, Alessandria
2022-09-08
Recruiting
GlaxoSmithKline
Phase 3
109
Bologna, Catania, Milan, Naples, Novara, Pavia, Roma, Treviso
2022-09-06
Active, closed
Hoffmann-La Roche
Phase 3
132
Pavia, Orbassano, Verona
2022-08-30
Recruiting
Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
NCT06899789Immune Checkpoint Inhibitors-induced Colitis, Advanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney Adenocarcinoma, Ileo-colitis, Immune Mediated-colitis
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
250
Pavia
2022-07-29
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Observational
1,426
Pavia
2022-07-22
Active, closed
Incyte Corporation
Phase 1/2
53
Ravenna, Milan, Pavia, Monza, Candiolo, Pisa, Perugia
2022-07-19
Active, closed
GlaxoSmithKline
Phase 3
163
Bari, Brescia, Florence, Milan, Pavia, Pisa, Roma, Torrette AN
2022-07-14
Active, closed
Novartis Pharmaceuticals
Phase 3
452
Pavia, Udine
2022-07-14
Active, closed
Biohaven Pharmaceuticals, Inc.
Phase 3
269
Bologna, Gussago, Pavia, Roma
2022-07-06
Recruiting
AIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944Head and Neck Carcinoma
Italian Head&Neck Society
Observational
7,000
Candiolo, Florence, Lecce, Milan, Pavia, Roma, Verona
2022-07-06
Active, closed
Janssen Research & Development, LLC
Phase 2
36
Ancona, Milan, Pavia, Roma
2022-07-05
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
4,000
Pavia
2022-07-01
Active, closed
Corcept Therapeutics
Phase 3
381
Catania, Legnago, Milan, Pavia, Roma, Rome, Torino, Treviso
2022-06-29
Active, closed
Cogent Biosciences, Inc.
Phase 2
237
Bologna, Catania, Florence, Pavia, Ravenna
2022-06-27
Recruiting
Unveiling the Germline Predisposition to Myeloproliferative Neoplasms
NCT07204392Myeloproliferative Disease, Germline Mutation
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
313
Pavia
2022-06-27
Active, closed
Celgene
Phase 3
939
Rome, Bologna, Catania, Genova, Milan, Novara, Pavia, Pisa
2022-06-23
Active, closed
Sanofi
Phase 3
531
Torette, Meldola, Rome, Bologna, Brescia, Pavia
2022-06-23
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
200
Pavia
2022-06-21
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
9,000
Pavia
2022-06-09
Active, closed
Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.
NCT06347588Occult Hepatitis B Infection in Cancer Patients
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
60
Pavia
2022-06-06
Active, closed
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003Clinical High Risk, Psychosis, Remission, Conversion
Brigham and Women's Hospital
Observational
2,617
Pavia
2022-06-02
Recruiting
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
NCT05483374Head and Neck Cancer, Nasopharynx Cancer, Nasal Cavity and Paranasal Sinus Cancer, Salivary Gland Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
13,600
Genova, Milan, Rozzano, Pavia, Prato, Roma
2022-05-31
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Bari, Bologna, Genova, Milan, Pavia, Roma, Torino
2022-05-30
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Florence, Genova, Milan, Padova, Pavia, Roma, Torino, Trieste
2022-05-23
Active, closed
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
219
Pavia
2022-05-06
Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Esophageal Cancer, Radiotherapy, Side Effect, Proton Therapy
University of Aarhus
Phase 3
396
Milan, Pavia, Trento
2022-05-01
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Bologna, Genova, Pavia, Piacenza
2022-04-05
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Meldola, Bergamo, Bologna, Brescia, Florence, Milan, Pavia, Pesaro
2022-04-01
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Turin, Florence, Genova, Milan, Pavia, Reggio Emilia, Roma
2022-03-29
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Bologna, Brescia, Florence, Genova, Messina, Milan, Naples, Pavia
2022-03-15
Active, closed
BeOne Medicines
Phase 3
799
Aviano, Bologna, Florence, Milan, Novara, Padova, Pavia, Reggio Emilia
2022-03-10
Recruiting
Local Registry of Central Nervous System Infections (ReCeNSI)
NCT07364539Central Nervous System (CNS) Infection
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
520
Pavia
2022-03-04
Recruiting
Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
NCT06309251Drug Resistant Epilepsy, Autism Spectrum Disorder, Chronic Migraine, Brain Tumor, Pediatric
Danone Nutricia SpA Società Benefit
Observational
100
Milan, Pavia, Roma
2022-03-01
Active, closed
Janssen Research & Development, LLC
Phase 2
151
Naples, Pavia, Roma
2022-03-01
Recruiting
Meyer Children's Hospital IRCCS
Observational
290
Florence, Bari, Brescia, Catanzaro, Lecce, Milan, Padova, Pavia
2022-02-10
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
300
Pavia
2022-02-08
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Ferrara, Milan, Naples, Palermo, Pavia, Rozzano, Terni
2022-02-07
Active, closed
AstraZeneca
Phase 3
1,051
Brescia, Florence, Lucca, Meldola, Orbassano, Parma, Pavia, Roma
2022-02-07
By invitation
UCB Biopharma SRL
Phase 3
300
Genova, Milan, Pavia, Roma
2022-02-03
Active, closed
UCB Biopharma SRL
Phase 3
113
Pavia, Roma, Verona
2022-02-02
Recruiting
National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
NCT05219903Eosinophilic Gastrointestinal Disorders, Eosinophilic Esophagitis, Eosinophilic Gastritis or Gastroenteritis, Eosinophilic Colitis
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
300
Pavia
2022-01-20
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
151
Milan, Pavia
2022-01-04
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Brindisi, Foggia, Pozzilli, Messina, Modena, Pavia, Orbassano, Naples
2021-12-13
Recruiting
UCB Biopharma SRL
Phase 3
350
Catanzaro, Genova, Milan, Pavia, Roma
2021-12-07
Recruiting
H. Lundbeck A/S
Phase 3
600
Rome, Genoa, Milan, Cagliari, Florence, Pisa, Pavia
2021-12-01
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Milan, Florence, Bologna, Catania, Pavia, Salerno, Verona, Vicenza
2021-11-30
Active, closed
Gilead Sciences
Phase 3
603
Bergamo, Brescia, Catania, Catanzaro, Cremona, Milan, Pavia, Roma
2021-11-17
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
76
Pavia
2021-11-06
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Arezzo, Florence, Pisa, Pavia
2021-10-27
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Bari, Bergamo, Bologna, Florence, Meldola, Pavia, Roma, Turin
2021-10-14
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Roma, Bologna, Genova, Messina, Milan, Naples, Pavia
2021-09-21
Active, closed
Bristol-Myers Squibb
Phase 3
338
Catania, Pavia, Perugia, Roma
2021-09-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Rome, Milan, Pavia
2021-09-15
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
102
Pavia
2021-09-13
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,725
Pavia
2021-09-09
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Catania, Cefalù, Milan, Naples, Pavia, Roma
2021-07-15
Active, closed
Bristol-Myers Squibb
Phase 3
670
Genova, Pavia, Udine, Verona
2021-07-13
Recruiting
Enterome
Phase 1/2
80
Bologna, Naples, Pavia
2021-07-05
Recruiting
H. Lundbeck A/S
Phase 3
285
Pavia, Rome, Milan, Cagliari, Genoa
2021-06-30
Recruiting
Longitudinal Registry Including Patients Treated With Heavy Particles
NCT05203250Cancer, Oncology, Radiation Exposure, Radiotherapy Side Effect
CNAO National Center of Oncological Hadrontherapy
Observational
3,000
Pavia
2021-06-04
Recruiting
Unconscious Processing in Decision-making
NCT05774847Healthy Volunteers
Istituti Clinici Scientifici Maugeri SpA
Observational
200
Pavia
2021-05-24
Active, closed
Bristol-Myers Squibb
Phase 3
681
Cremona, Florence, Meldola, Milan, Padova, Parma, Pavia, Roma
2021-05-21
Active, closed
Savara Inc.
Phase 3
164
Pavia
2021-05-19
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
35
Pavia
2021-05-11
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103Metastatic Non Small Cell Lung Cancer
DrugLifileucel
Iovance Biotherapeutics, Inc.
Phase 2
170
Florence, Pavia, Pesaro, Piemonte
2021-05-07
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Active, closed
Hoffmann-La Roche
Phase 3
751
Chieti, Bari, Naples, Rome, Genoa, Milan, Montichiari, Pavia
2021-03-24
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Not applicable
86
Pavia
2021-03-17
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
500
Pavia
2021-03-16
Recruiting
Effort-based Decision-making and CPAP Adherence
NCT04557293Obstructive Sleep Apnea, Adherence
Istituti Clinici Scientifici Maugeri SpA
Not applicable
64
Pavia
2021-03-10
Recruiting
Syndax Pharmaceuticals
Phase 2
296
Brescia, Milan, Monza, Pavia, Roma, Torino
2021-03-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Meldola, Rozzano, Orbassano, Arezzo, Bari, Milan, Pavia, Roma
2021-02-25
Recruiting
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
NCT05457595Tumor Recurrence, Malignant Epithelial Neoplasm of Vulva, Malignant Epithelial Tumor of Ovary, Malignant Epithelial Neoplasm
CNAO National Center of Oncological Hadrontherapy
Not applicable
55
Pavia
2021-02-24
Recruiting
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
NCT06861257Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, Non-malignant Disorders
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Bologna, Brescia, Genova, Milan, Monza, Padova, Pavia, Torino
2021-02-24
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Aviano, Meldola, Milan, Pavia, Verona
2021-02-23
Active, closed
Stichting European Myeloma Network
Phase 2
160
Ancona, Bologna, Bolzano, Brescia, Florence, Genova, Pavia, Terni
2021-02-22
Recruiting
AB Science
Phase 3
495
Baggiovara, Brescia, Gussago, Milan, Novara, Padova, Pavia, Torino
2021-02-02
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
Pavia, Catania, Orbassano, Padova, Palermo, Roma
2021-01-29
Recruiting
Sonification Techniques for Gait Training
NCT04876339Parkinson Disease, Stroke, Multiple Sclerosis
Istituti Clinici Scientifici Maugeri SpA
Not applicable
120
Pavia
2021-01-18
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Observational
219
Pavia
2021-01-15
Active, closed
Genmab
Phase 3
483
Bari, Bergamo, Brescia, Meldola, Milan, Novara, Pavia, Ravenna
2021-01-13
Recruiting
Multiple Human Papillomavirus Infections in the Development of CIN
NCT06862102CIN - Cervical Intraepithelial Neoplasia, HPV, HPV Vaccines
DrugHPV vaccine
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
152
Pavia
2021-01-08
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
50
Pavia
2020-12-28
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Milan, Genova, Naples, Pavia
2020-12-11
Active, closed
Hoffmann-La Roche
Phase 3
769
Naples, Rome, Gallarate, Milan, Pavia, Turin
2020-12-03
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Observational
105
Pavia
2020-12-01
Active, closed
Genmab
Phase 1/2
543
Bergamo, Bologna, Candiolo, Meldola, Milan, Pavia, Reggio Emilia
2020-11-03
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Milan, Pavia, Rome
2020-10-15
Recruiting
QualiMed Innovative Medizinprodukte GmbH
Observational
198
Rozzano, Forlì, Pavia, Roma
2020-10-03
Active, closed
GlaxoSmithKline
Phase 3
302
Bologna, Milan, Pavia, Roma
2020-10-01
Active, closed
European Myeloma Network B.V.
Phase 3
302
Ancona, Bari, Bologna, Brescia, Cuneo, Florence, Novara, Pavia
2020-09-25
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Udine, Brescia, Florence, Foggia, Meldola, Milan, Pavia, Ravenna
2020-09-16
Recruiting
CNAO National Center of Oncological Hadrontherapy
Not applicable
9
Pavia
2020-09-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Naples, Pavia, Pisa, Roma
2020-08-25
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,200
Pavia
2020-08-20
Recruiting
San Matteo Endocarditis Registry STEADY
NCT07346222Endocarditis Infective
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
418
Pavia
2020-08-20
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
30
Pavia
2020-08-17
Recruiting
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
NCT05040373Hereditary Transthyretin-mediated (hATTR) Amyloidosis, Polyneuropathy
Alnylam Pharmaceuticals
Observational
10
Pavia
2020-08-01
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
1,500
Bergamo, Milan, Novara, Padova, Pavia, Roma, Reggio Emilia
2020-07-16
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
600
Pavia
2020-07-01
Active, closed
Actelion
Phase 3
935
Milan, Modena, Nuoro, Pavia, Pisa, Roma
2020-06-30
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,000
Pavia
2020-05-20
Active, closed
GlaxoSmithKline
Phase 3
325
Bologna, Brescia, Catanzaro, Milan, Pavia, Perugia, Ravenna, Roma
2020-04-02
Recruiting
A Registry of AL Amyloidosis (ReAL)
NCT04839003AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
5,000
Pavia
2020-02-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Verona, Arezzo, Bari, Bologna, Milan, Modena, Padova, Pavia
2020-02-27
Active, closed
Istituti Clinici Scientifici Maugeri SpA
Observational
1,950
Pavia
2020-02-04
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Bologna, Brescia, Genova, Milan, Monza, Naples, Pavia, Rome
2020-01-29
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
50
Pavia
2020-01-15
Recruiting
Melanoma and Skin Cancer Trials Limited
Not applicable
2,998
Padova, Pavia, Torino
2019-12-17
Active, closed
CStone Pharmaceuticals
Phase 3
534
Feltre, Padova, Peschiera del Garda, Cremona, Pavia
2019-12-13
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Brescia, Campobasso, Novara, Palermo, Pavia, Ravenna, Reggio Calabria, Roma
2019-12-12
Rows per page Showing 1–500 of 562
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/pavia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 562 of those studies with a site in Pavia.

How many clinical trials are recruiting in Pavia?

339 of the 562 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 25 have not yet opened recruitment, 180 are active but closed to new participants, and 18 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pavia), 562 studies
PhaseStudiesRecruitingShare
Observational18914233.6%
Phase 31798231.9%
Not applicable936516.5%
Phase 2713512.6%
Phase 2/31272.1%
Phase 1/21162%
Phase 1400.7%
Phase 4320.5%

Most active sponsors

Lead sponsors with the most studies (Pavia)
Lead sponsorStudiesRecruiting
Fondazione IRCCS Policlinico San Matteo di Pavia11793
Istituti Clinici Scientifici Maugeri SpA3425
University of Pavia2410
AstraZeneca2313
Hoffmann-La Roche143
Novartis Pharmaceuticals146
Janssen Research & Development, LLC127
IRCCS National Neurological Institute "C. Mondino" Foundation118
Takeda98
GlaxoSmithKline84
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.